Azacitidine in outpatient treatment – single center experience

AIM OF THE STUDY: Azacitidine is a hypomethylating agent which is used in the treatment of myelodysplastic syndromes, acute myeloid leukemia and chronic myelomonocytic leukemia. Because of good tolerance to the drug, azacitidine can be administered both during hospitalization and in an outpatient se...

Descripción completa

Detalles Bibliográficos
Autores principales: Rybka, Justyna, Stefanko, Ewa, Bogucka-Fedorczuk, Aleksandra, Butrym, Aleksandra, Poręba, Rafał, Kuliczkowski, Kazimierz, Wróbel, Tomasz
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Termedia Publishing House 2016
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4731453/
https://www.ncbi.nlm.nih.gov/pubmed/26843844
http://dx.doi.org/10.5114/wo.2015.56653

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4731453/
https://www.ncbi.nlm.nih.gov/pubmed/26843844
http://dx.doi.org/10.5114/wo.2015.56653

Ejemplares similares